However, from many reports, a conclusive proposal, that is, a combination of CSF measures appears to emerge, that may well be able to differentiate DLB from other dementias: α-synuclein reduction in early DLB, a correlation between CSF α-synuclein and Aβ42 measures (characteristic for DLB only), and t-tau and p-tau181 profile (differentiating AD from DLB) [9]. This evidence concerns the gene SNCA and Alzheimer disease.